Executive Editor, Molecular Medicine
Chris Czura, PhD is a molecular biologist who has been studying vagus nerve stimulation for the past 20 years. He has made seminal discoveries in neural control of bleeding and inflammation. Results of his research have supported the development of two bioelectronic medicine startup companies, the first of which recently closed Series D with total funding in excess of $80m to commercialize a proprietary implantable vagus nerve stimulator to treat rheumatoid arthritis. The second company is currently enrolling subjects for a clinical trial of a proprietary non-invasive vagus nerve stimulator to treat postpartum hemorrhage.
Dr. Czura served as Vice President of Scientific Affairs at the Feinstein Institute for Medical Research (Northwell Health, Manhasset, NY), overseeing all aspects of laboratory operations, the annual budget, and construction and renovation projects. He coordinated strategic plan development with the President and the Board of Directors, and represented the research portfolio to senior leadership of Northwell Health.
Dr. Czura has authored or co-authored over 100 peer-reviewed papers, book chapters and meeting abstracts, and presented to audiences in science, military, industry, venture capital and philanthropy. He has been awarded one international patent and has a second patent pending, and has raised over $50 million in sponsored research agreements and laboratory construction grants.